Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 11, 2011, Pages 1522-1527

  Nansera, Denis ^a   Graziano, F M ^b   Friedman, D J ^c   Bobbs, M K ^b   Jones, A N ^b   Hansen, Karen E ^b  

^a MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Calcium; HIV; Tuberculosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; CALCIUM; HEMOGLOBIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TUBERCULOSIS; UGANDA; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BODY MASS INDEX; CALCIUM; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUNLIGHT; TUBERCULOSIS; UGANDA; VITAMIN D; YOUNG ADULT;

EID: 80053949855     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0701     Document Type: Article

References (30)

1. Highleyman L. Mortality trends: towards a new defi nition of AIDS? Beta 2005; 17: 18-28.
2. Stead W W, Senner J W, Reddick W T, Lofgren J P. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990; 322: 422-427. (Pubitemid 20059510)
3. Lochner J D, Schneider D J. The relationship between tuberculosis, vitamin D, potassium and AIDS. A message for South Africa? S Afr Med J 1994; 84: 79-82.
4. Garin B, Glaziou P, Kassa-Kelembho E, Yassibanda S, Mbelesso P, Morvan J. High mortality rates among patients with tuberculosis in Bangui, Central African Republic. Lancet 1997; 350: 1298. (Pubitemid 28036644)
5. Van den Broek J, Mfi nanga S, Moshiro C, O'Brien R, Mugomela A, Lefi M. Impact of human immunodefi ciency virus infection on the outcome of treatment and survival of tuberculosis patients in Mwanza, Tanzania. Int J Tuberc Lung Dis 1998; 2: 547-552. (Pubitemid 28320061)
6. Liu P T, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773.
7. Liu P T, Stenger S, Tang D H, Modlin R L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007; 179: 2060-2063.
8. Ministry of Health, Republic of Uganda. Manual of the National Tuberculosis and Leprosy Programme. 2nd ed. Kampala, Uganda: MOH, 2010.
9. Ministry of Health Uganda. National antiretroviral treatment guidelines for adults, adolescents and children. 3rd ed. Kampala, Uganda: Ministry of Health, 2009.
10. Lensmeyer G L, Wiebe D A, Binkley N, Drezner M K. HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 2006; 52: 1120-1126. (Pubitemid 43794425)
11. Teichmann J, Stephan E, Lange U, et al. Osteopenia in HIVinfected women prior to highly active antiretroviral therapy. J Infect 2003; 46: 221-227. (Pubitemid 36758180)
12. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington DC, USA: National Academies Press, 2011.
13. Manosuthi W, Van Tieu H, Mankatitham W, et al. Clinical case defi nition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. Aids 2009; 23: 2467-2471.
14. Van den Bout-Van den Beukel C J, Fievez L, Michels M, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008; 24: 1375-1382.
15. Rodriguez M, Daniels B, Gunawardene S, Robbins G K. High frequency of vitamin D defi ciency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 2009; 25: 9-14.
16. Coodley G O, Coodley M K, Nelson H D, Loveless M O. Micronutrient concentrations in the HIV wasting syndrome. AIDS 1993; 7: 1595-1600. (Pubitemid 24008852)
17. Kuehn E W, Anders H J, Bogner J R, Obermaier J, Goebel F D, Schlondorff D. Hypocalcaemia in HIV infection and AIDS. J Intern Med 1999; 245: 69-73. (Pubitemid 29049145)
18. Wejse C, Olesen R, Rabna P, et al. Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr 2007; 86: 1376-1383. (Pubitemid 350126241)
19. Felekem Y, Abdulkadir J, Mshana R, et al. Low levels of serum calcidiol in an African population compared to a North European population. Eur J Endocrinol 1999; 141: 358-360. (Pubitemid 29529488)
20. Allali F, El Aichaoui S, Khazani H, et al. High prevalence of hypovitaminosis D in Morocco: relationship to lifestyle, physical performance, bone markers and bone mineral density. Semin Arthritis Rheum 2009; 38: 444-451.
21. Glew R H, Crossey M J, Polanams J, Okolie H I, VanderJagt D J. Vitamin D status of seminomadic Fulani men and women. J Natl Med Assoc 2010; 102: 485-490.
22. Nnoaham K E, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J E pidemiol 2008; 37: 113-119. (Pubitemid 351228619)
23. Looker A C, Pfeiffer C M, Lacher D A, Schleicher R L, Picciano M F, Yetley E A. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008; 88: 1519-1527.
24. Zadshir A, Tareen N, Pan D, Norris K, Martins D. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 2005; 15 (Suppl 5): S97-S101.
25. Marcos M M, Gabr A A, Samuel S, et al. Vitamin D administration to tuberculous children and its value. Boll Chim Farm 1998; 137: 157-164. (Pubitemid 29135376)
26. Nursyam E W, Amin Z, Rumende C M. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006; 38: 3-5.
27. Wejse C, Gomes V F, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009; 179: 843-850.
28. Yamshchikov A V, Desai N S, Blumberg H M, Ziegler T R, Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract 2009; 15: 438-449.
29. Fawzi W W, Msamanga G I, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004; 351: 23-32. (Pubitemid 38857244)
30. Sato K A, Gray R W, Lemann J Jr. Urinary excretion of 25- h ydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med 1982; 99: 325-330. (Pubitemid 12138201)